Jim Cramer on the White House declining Pfizer's offer for additional Covid-19 vaccine doses
Dr. Scott Gottlieb, a member of Pfizer’s board, told CNBC on Tuesday the company’s offers to provide the U.S. additional doses of its coronavirus vaccine in 2021 was declined by the Trump administration. CNBC's Jim Cramer and David Faber discuss. Subscribe to CNBC PRO for access to investor and analyst insights: https://cnb.cx/2Vtntx6
President Donald Trump is expected to sign an executive order on Tuesday designed to ensure that U.S. efforts to assist other countries in vaccinating their populations against Covid-19 take on a lower priority than domestic inoculations.
In a call with reporters Monday afternoon, a senior administration official described the order as primarily a “reaffirmation of the president’s commitment to America First.” Additionally, the order directs a handful of government agencies, including the State Department and the United States Agency for International Development, to work together to help international partners and allies procure Covid vaccines, the official said.
CNBC has not reviewed the proposed text of the executive order, which could prove to be largely symbolic. The plans for the executive order were earlier reported by Fox News.
An administration official told NBC News on Monday that the timeline for providing foreign assistance will be shaped by supply and demand but is anticipated to begin in the second quarter. President-elect Joe Biden will take office on Jan. 20 and is likely to shape his own policy for obtaining and distributing Covid-19 vaccines, possibly limiting the impact of Trump’s order.
Trump is expected to sign the order after delivering remarks at the start of a Covid-19 summit at the White House on Tuesday, a senior administration official said on Monday’s call. The event will feature talks with administration officials and drug distributors, who will discuss the process of reviewing vaccine candidates and distributing them, the official said.
Trump has largely ignored the growing coronavirus crisis in recent weeks despite a surge in infections and a mounting death toll that has surpassed 2,000 fatalities per day, instead focusing on legal efforts to overturn the results of November’s presidential election.
Nonetheless, the signing will come at a particularly critical phase of vaccine development.
» Subscribe to CNBC TV: https://cnb.cx/SubscribeCNBCtelevision
» Subscribe to CNBC: https://cnb.cx/SubscribeCNBC
» Subscribe to CNBC Classic: https://cnb.cx/SubscribeCNBCclassic
Turn to CNBC TV for the latest stock market news and analysis. From market futures to live price updates CNBC is the leader in business news worldwide.
The News with Shepard Smith is CNBC’s daily news podcast providing deep, non-partisan coverage and perspective on the day’s most important stories. Available to listen by 8:30pm ET / 5:30pm PT daily beginning September 30: https://www.cnbc.com/2020/09/29/the-news-with-shepard-smith-podcast.html?__source=youtube%7Cshepsmith%7Cpodcast
Connect with CNBC News Online
Get the latest news: http://www.cnbc.com/
Follow CNBC on LinkedIn: https://cnb.cx/LinkedInCNBC
Follow CNBC News on Facebook: https://cnb.cx/LikeCNBC
Follow CNBC News on Twitter: https://cnb.cx/FollowCNBC
Follow CNBC News on Instagram: https://cnb.cx/InstagramCNBC
https://www.cnbc.com/select/best-credit-cards/
#CNBC
#CNBCTV
Видео Jim Cramer on the White House declining Pfizer's offer for additional Covid-19 vaccine doses канала CNBC Television
President Donald Trump is expected to sign an executive order on Tuesday designed to ensure that U.S. efforts to assist other countries in vaccinating their populations against Covid-19 take on a lower priority than domestic inoculations.
In a call with reporters Monday afternoon, a senior administration official described the order as primarily a “reaffirmation of the president’s commitment to America First.” Additionally, the order directs a handful of government agencies, including the State Department and the United States Agency for International Development, to work together to help international partners and allies procure Covid vaccines, the official said.
CNBC has not reviewed the proposed text of the executive order, which could prove to be largely symbolic. The plans for the executive order were earlier reported by Fox News.
An administration official told NBC News on Monday that the timeline for providing foreign assistance will be shaped by supply and demand but is anticipated to begin in the second quarter. President-elect Joe Biden will take office on Jan. 20 and is likely to shape his own policy for obtaining and distributing Covid-19 vaccines, possibly limiting the impact of Trump’s order.
Trump is expected to sign the order after delivering remarks at the start of a Covid-19 summit at the White House on Tuesday, a senior administration official said on Monday’s call. The event will feature talks with administration officials and drug distributors, who will discuss the process of reviewing vaccine candidates and distributing them, the official said.
Trump has largely ignored the growing coronavirus crisis in recent weeks despite a surge in infections and a mounting death toll that has surpassed 2,000 fatalities per day, instead focusing on legal efforts to overturn the results of November’s presidential election.
Nonetheless, the signing will come at a particularly critical phase of vaccine development.
» Subscribe to CNBC TV: https://cnb.cx/SubscribeCNBCtelevision
» Subscribe to CNBC: https://cnb.cx/SubscribeCNBC
» Subscribe to CNBC Classic: https://cnb.cx/SubscribeCNBCclassic
Turn to CNBC TV for the latest stock market news and analysis. From market futures to live price updates CNBC is the leader in business news worldwide.
The News with Shepard Smith is CNBC’s daily news podcast providing deep, non-partisan coverage and perspective on the day’s most important stories. Available to listen by 8:30pm ET / 5:30pm PT daily beginning September 30: https://www.cnbc.com/2020/09/29/the-news-with-shepard-smith-podcast.html?__source=youtube%7Cshepsmith%7Cpodcast
Connect with CNBC News Online
Get the latest news: http://www.cnbc.com/
Follow CNBC on LinkedIn: https://cnb.cx/LinkedInCNBC
Follow CNBC News on Facebook: https://cnb.cx/LikeCNBC
Follow CNBC News on Twitter: https://cnb.cx/FollowCNBC
Follow CNBC News on Instagram: https://cnb.cx/InstagramCNBC
https://www.cnbc.com/select/best-credit-cards/
#CNBC
#CNBCTV
Видео Jim Cramer on the White House declining Pfizer's offer for additional Covid-19 vaccine doses канала CNBC Television
Показать
Комментарии отсутствуют
Информация о видео
Другие видео канала
Jim Cramer on Tesla's plans to sell $5 billion in stock 'from time to time'Stocks move lower as stimulus talks stall and Covid-19 spike weigh on sentimentPfizer, Moderna Decline To Attend WH Vaccine Summit | Morning Joe | MSNBCLot of pent-up demand for crypto in PayPal, Square: Fintech research analystWhat could lie store for IPOs and SPACs in 2021: ETF analystsStick with a barbell approach, don't go all in on cyclicals: InvestorWhite House declined Pfizer's offer to secure more Covid-19 vaccine doses: Board member GottliebJim Cramer: Return of individual investors changed the entire character of the marketFDA: Pfizer's Covid-19 vaccine data did not raise safety concernsNext big money opportunity emerging?Vaccine stocks aren't the way to play the reopening trade: AnalystH&R Block CEO on strategy to focus on small businessesGoldman Sachs' strategist: Expect significant equity market upside in 2021AstraZeneca-Oxford First To Publish Final-Stage Vaccine Trial ResultsThe upside of DoorDash is in its subscription service: Tech investorJim Cramer on DoorDash public debut: 'I recommend being careful'Trump To Sign Executive Order To Prioritize Covid-19 Vaccine Shipment To US | MTP Daily | MSNBCDr. Vin Gupta On Covid-19 Vaccine: 'It Doesn’t Look Like There’s Any Serious Adverse Events' | MSNBCJim Cramer: Disney remains one of the best stocks to ownUK rolls out 1st doses of Pfizer’s COVID-19 vaccine